Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer—The Possibility or the Necessity?
Article in Journal of Personalized Medicine (December 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Tenofovir alone or combined with doxorubicin abrogates DMBA-induced mammary cell carcinoma: An insight into its modulatory impact on oxidative/Notch/apoptotic signaling
Article in Life Sciences (May 2023)
Molecular cluster mining of high-grade serous ovarian cancer via multi-omics data analysis aids precise medicine
Article in Journal of Cancer Research and Clinical Oncology (May 2023)